2020 Nobel Laureate Jennifer Doudna guest speaker on CRISPR and coronavirus

Jennifer Doudna, the 2020 Nobel Laureate in Chemistry, will be the guest speaker at the upcoming Distinguished Speaker Series in Research and Innovation on Oct. 30 at 10:30 a.m. She will talk about her work on CRISPR and its intersections with COVID-19. The online event, co-organized by the UC Davis Office of Research and the School of Medicine, will be live but registration is required.

Prof. Jennifer Doudna, the 2020 Nobel Laureate in chemistry. Prof. Jennifer Doudna, the 2020 Nobel Laureate in chemistry.

Doudna is a Howard Hughes Medical Institute Investigator at UC Berkeley and founder of the Innovative Genomics Institute. She is best known for her co-development of CRISPR, a method for genome editing.

Doudna is also the Li Ka Shing Chancellor’s Chair and a professor in the Departments of Chemistry and Molecular and Cell Biology. Her co-discovery of CRISPR-Cas9 genetic engineering technology has disrupted human and agricultural genomics research forever. This genome-editing technology enables scientists to change or remove genes quickly and with great precision. Labs worldwide have re-directed their research programs to incorporate this new tool, creating a CRISPR revolution with huge implications across biology and medicine.

Doudna is a leader in public discussion of the ethical implications of genome editing for human biology and societies. She advocates for thoughtful approaches to the development of policies around the use of CRISPR-Cas9.

She has received many prizes for her discoveries, including the Japan Prize (2016), the Kavli Prize (2018), the LUI Che Woo Welfare Betterment Prize (2019) and the Wolf Prize in Medicine (2020). In 2015, Doudna was named by Time Magazine as one of the 100 most influential people in the world.

This event is hosted by the UC Davis Office of Research and UC Davis School of Medicine. For registration: https://ucdavis.zoom.us/webinar/register/WN_37gY9DEIRUuEGsP6TWPyhw

/Public Release. The material in this public release comes from the originating organization and may be of a point-in-time nature, edited for clarity, style and length. View in full here.